Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03710707
What this trial is testing

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 29
Early research (Phase 1)Study completedNCT02099071
What this trial is testing

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 65
Early research (Phase 1)Study completedNCT02098967
What this trial is testing

The Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Who this might be right for
Neoplasms, Myelogenous Leukemia, Acute
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Early research (Phase 1)Study completedNCT05327595
What this trial is testing

LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 80
Early research (Phase 1)WithdrawnNCT02285465
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects

Who this might be right for
Healthy VolunteersPharmacokinetics of ASP3700
Astellas Pharma Europe B.V.
Early research (Phase 1)Looking for participantsNCT07423000
What this trial is testing

PVT401 in Healthy Subjects

Who this might be right for
Inflammatory Bowel Disease (IBD)
Parvus Therapeutics, Inc. 36
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Early research (Phase 1)Study completedNCT04889157
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 20
Early research (Phase 1)Not Yet RecruitingNCT07765511
What this trial is testing

Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 60
Early research (Phase 1)Looking for participantsNCT07481357
What this trial is testing

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric (Stomach) CancerGastroEsophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd. 51
Testing effectiveness (Phase 2)Study completedNCT04435665
What this trial is testing

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
NFlection Therapeutics, Inc. 48
Early research (Phase 1)Study completedNCT01596712
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects

Who this might be right for
Allergy
Novartis Pharmaceuticals 209
Early research (Phase 1)UnknownNCT04297865
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects

Who this might be right for
Healthy
HK inno.N Corporation 55
Early research (Phase 1)Study completedNCT06673667
What this trial is testing

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

Who this might be right for
Healthy Participants Study
Kymera Therapeutics, Inc. 118
Early research (Phase 1)Study completedNCT01554800
What this trial is testing

Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
MedImmune LLC 16
Early research (Phase 1)Study completedNCT01720537
What this trial is testing

Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Who this might be right for
Hypercholesterolemia
Pfizer 133
Early research (Phase 1)Study completedNCT02709928
What this trial is testing

Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects

Who this might be right for
Healthy Adults, Elderly Subjects
Theravance Biopharma 50
Testing effectiveness (Phase 2)Study completedNCT01043185
What this trial is testing

Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 27
Early research (Phase 1)Study completedNCT02183415
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 77
Next Page